CRISPR Market
Global CRISPR Market Size, Share & Trends Analysis Report by Application (Cell Line Engineering, CRISPR Plasmid, Gene Database/Gene Library, Genetic Engineering, Genetically Modified Organism or Crops, Genome Editing, and Human Stem Cells), and by End-Users (Academic Institutes, Biotechnology Companies, Pharmaceuticals Companies, and Research and Development Institutes) Forecast Period (2022-2028) Update Available - Forecast 2024-2030
The global CRISPR market is anticipated to grow at a significant CAGR of 36.8 % during the forecast period. CRISPR stands for clustered regularly interspaced short palindromic repeats, it is a DNA sequence in bacteria. It forms the basis of the genome editing technology, CRISPR-CAS9, which allows permanent modification of genes within organisms. CRISPR also plays a vital role in bacterial defense systems. The increasing prevalence of genetic birth disorders and the rising demand for synthetic genes are expected to be the key factors that are driving the growth of the Global CRISPR market. According to the Cleveland Clinic, between 2% and 3% of infants have one or more defects at birth. That number increases to 5% by age one (not all defects are discovered directly after your child’s birth). One out of every 33 babies born in the US is affected by birth defects.
Impact of COVID-19 Pandemic on Global CRISPR Market
The COVVID-19 pandemic poses a significant threat to global public health and societal stability and has become a significant global public health problem. Regrettably, current diagnostic and therapeutic methods to prevent and control COVID-19 have many limitations. CRISPR technology has emerged as a potential complement to conventional methods in recent years. Biomedicine has extensively used biological tools based on the CRISPR systems. They are helpful in pathogen detection, clinical antiviral treatment, and drug and vaccine discovery. Therefore, CRISPR/Cas technology could be promising in preventing and treating SARS-CoV-2 and other emerging infectious diseases.
Segmental Outlook
The global CRISPR market is segmented based on the application and end-user. Based on the application, the market is segmented into cell line engineering, CRISPR plasmid, gene database/gene library, genetic engineering, genetically modified organism or crops, genome editing, and human stem cells. Based on the end-user, the market is sub-segmented into academic institutes, biotechnology companies, pharmaceutical companies, and research and development institutes. The above-mentioned segments can be customized as per the requirements. Among the end-user segment, cell line engineering is expected to provide lucrative growth to the market. CRISPR is a novel gene-editing tool that is used for both therapeutic and diagnostic applications. Biotechnology companies such as Sherlock Biosciences, are using CRISPR to develop diagnostic tests to detect major diseases.
Global CRISPR Market Share by Application, 2021 (%)
The Genome Editing Segment is Expected to Hold the Significant Share in the Global CRISPR Market over the Forecast Period.
Among the application, the genome editing segment is expected to hold a significant share in the market during the forecast period. Based on engineered or bacterial nucleases, the development of genome editing technologies has opened up the possibility of directly targeting and modifying genomic sequences in almost all eukaryotic cells. Genome editing has begun to show extraordinary potential in a variety of fields, ranging from basic research to applied biotechnology and biomedical research.
Regional Outlooks
The global CRISPR market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. The Asia Pacific is estimated to be the fastest-growing region owing to the increasing number of drug discovery activities in the region during the forecast period.
Global CRISPR Market Growth, by Region 2022-2028
The North American Region is Expected to hold the Considerable Share in the Global CRISPR Market over the Forecast Period.
The North American region is expected to hold a considerable share region in the global CRISPR market owing to its high number of research and development activities in the region. According to the Innovative Genomics Institute, In the US, the Food and Drug Administration (FDA) evaluates new disease treatments for safety and efficacy through clinical trials on patient volunteers. The current trials using CRISPR-based treatments are still in the early stages. That means that even if the treatments are safe and effective, they’re likely still a few years away from FDA approval and are broadly available to patients. Moreover, Current trials are underway in five treatment areas: blood disorders, cancers, eye disease, chronic infections, and protein-folding disorders.
Market Players Outlook
The major companies serving the global CRISPR market include Caribou Bioscience Inc., Cellectis SA, Crispr Therapeutics AG, Editas Medicine, Inc., Genscript Biotech Corp., Horizon Discovery Ltd., Lonza Group Ltd., Merck KGaA, Darmstadt, Origene Technologies, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2021, QIAGEN launched dedicated CRISPR products for rapid and simplified analysis of gene-editing experiments. The product launch marks QIAGEN’s dedicated solutions specific to the fast-growing field of CRISPR technology used for editing genomes and modifying gene functions.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global CRISPR market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1.Report Summary
?Current Industry Analysis and Growth Potential Outlook
?Impact of COVID-19 on the Global CRISPR Market
?Recovery Scenario of Global CRISPR Market
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.BY Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.Key Company Analysis
3.1.1.Overview
3.1.2.Financial Analysis
3.1.3.SWOT Analysis
3.1.4.Recent Developments
3.2.Key Strategy Analysis
3.3.Impact of Covid-19 on Key Players
4.Market Segmentation
4.1.Global CRISPR Market by Application
4.1.1.Cell Line Engineering
4.1.2.CRISPR Plasmid
4.1.3.Gene Database/Gene Library
4.1.4.Genetic Engineering
4.1.5.Genetically Modified Organism or Crops
4.1.6.Genome Editing
4.1.7.Human Stem Cells
4.2.Global CRISPR Market by End-User
4.2.1.Academic Institutes
4.2.2.Biotechnology Companies
4.2.3.Pharmaceuticals Companies
4.2.4.Research and Development Institutes
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.South Korea
5.3.5.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Addgene
6.2.AstraZeneca PLC
6.3.Bio-Rad Laboratories, Inc.
6.4.Caribou Bioscience Inc.
6.5.Cellectics SA
6.6.Crispr Therapeutics AG
6.7.Editas Medicine, Inc.
6.8.Genscript Biotech Corp.
6.9.Horizon Discovery Ltd.
6.10.Integrated DNA Technologies, Inc.
6.11.Intellia Therapeutics Inc.
6.12.Lonza Group Ltd.
6.13.Merck KGaA, Darmstadt
6.14.Origene Technologies, Inc.
6.15.Precision Bioscience, Inc.
6.16.Sangamo Therapeutics Inc.
6.17.Thermo Fisher Scientific
6.18.Transposagen Biopharmaceuticals, Inc.
1.GLOBAL CRISPR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
2.GLOBAL CRISPR FOR CELL LINE ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL CRISPR FOR CRISPR PLASMID MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL CRISPR FOR GENE DATABASE/GENE LIBRARY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5.GLOBAL CRISPR FOR GENETIC ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL CRISPR FOR GENETICALLY MODIFIED ORGANISM OR CROPS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7.GLOBAL CRISPR FOR GENOME EDITING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8.GLOBAL CRISPR FOR HUMAN STEM CELLS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9.GLOBAL CRISPR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
10.GLOBAL CRISPR FOR ACADEMIC INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11.GLOBAL CRISPR FOR BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12.GLOBAL CRISPR FOR PHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13.GLOBAL CRISPR FOR RESEARCH AND DEVELOPMENT INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14.GLOBAL CRISPR MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
15.NORTH AMERICAN CRISPR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16.NORTH AMERICAN CRISPR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17.NORTH AMERICAN CRISPR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
18.EUROPEAN CRISPR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19.EUROPEAN CRISPR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20.EUROPEAN CRISPR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
21.ASIA-PACIFIC CRISPR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22.ASIA-PACIFIC CRISPR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
23.ASIA-PACIFIC CRISPR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
24.REST OF THE WORLD CRISPR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
25.REST OF THE WORLD CRISPR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
26.REST OF THE WORLD CRISPR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL CRISPR MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL CRISPR MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL CRISPR MARKET, 2021-2028 (%)
4.GLOBAL CRISPR MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
5.GLOBAL CRISPR FOR CELL LINE ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL CRISPR FOR CRISPR PLASMID MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL CRISPR FOR GENE DATABASE/GENE LIBRARY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8.GLOBAL CRISPR FOR GENETIC ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL CRISPR FOR GENETICALLY MODIFIED ORGANISM OR CROPS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10.GLOBAL CRISPR FOR GENOME EDITING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.GLOBAL CRISPR FOR HUMAN STEM CELLS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12.GLOBAL CRISPR MARKET SHARE BY END-USER, 2021 VS 2028 (%)
13.GLOBAL CRISPR FOR ACADEMIC INSTITUTES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14.GLOBAL CRISPR FOR BIOTECHNOLOGY COMPANIES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15.GLOBAL CRISPR FOR PHARMACEUTICAL COMPANIES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16.GLOBAL CRISPR FOR RESEARCH AND DEVELOPMENT ISNTITUTES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17.GLOBAL CRISPR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18.US CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
19.CANADA CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
20.UK CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
21.FRANCE CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
22.GERMANY CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
23.ITALY CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
24.SPAIN CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
25.REST OF EUROPE CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
26.INDIA CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
27.CHINA CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
28.JAPAN CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
29.SOUTH KOREA CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
30.REST OF ASIA-PACIFIC CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
31.REST OF THE WORLD CRISPR MARKET SIZE, 2021-2028 ($ MILLION)
